Status
Conditions
About
This study uses number and size of ovarian follicles on the day of ovulation trigger as key determinants for oocytes yield to optimize outcomes in IVF and ICSI Protocols
Full description
Accurate prediction of oocyte yield is central to optimizing outcomes in in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) protocols. Among the key determinants, the number and size of ovarian follicles on the day of ovulation trigger have been consistently identified as critical predictors of both oocyte retrieval and maturation.
Several studies have demonstrated a strong association between follicle diameter and oocyte maturity. Follicles within the 16-22 mm range are significantly more likely to yield mature oocytes than smaller follicles (Haas et al., 2019; Mochtar et al., 2022). Analyses involving thousands of punctured follicles further confirmed that the likelihood of good-quality blastocyst formation increases progressively with follicle size up to approximately 19 mm, with diminishing returns thereafter (Weghofer et al., 2022).
More recently, large-scale data-driven approaches have refined these observations. A multicenter European cohort study of over 19,000 patients demonstrated that follicles measuring 13-18 mm contribute most substantially to the yield of metaphase-II (MII) oocytes, whereas the 14-20 mm range was most predictive of high-quality blastocyst development (Leijdekkers et al., 2024). Importantly, even after adjusting for age, ovarian reserve, and stimulation protocol, follicular size remained the dominant determinant of mature oocyte yield (Leijdekkers et al., 2024).
Despite these insights, there is still no standardized framework to estimate the minimum expected oocyte yield based on follicular size distribution. Given the pivotal role of oocyte number in clinical decision-making, counseling, and resource allocation, the development of a reliable predictive model represents an important unmet clinical need.
Despite this evidence, most studies have focused on average associations rather than defining a reliable minimum expected oocyte yield based on follicular size distribution. No standardized clinical model currently exists to translate follicle measurements into concrete expectations for the lowest anticipated number of retrieved oocytes. This lack of standardization limits clinicians' ability to optimize trigger timing, personalize stimulation protocols, and provide accurate counseling to patients regarding realistic outcomes. So, we are interested in this study to estimate the minimum number of oocytes retrieved based on the number and diameter of follicles measured on the day of ovulation trigger
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
60 participants in 1 patient group
Loading...
Central trial contact
Ahmad Rashad Mahmoud Mostafa, MBBCh; Karima Sobhy M.Kholeif, Ph.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal